Biosimulytics

Biosimulytics

Foundation date

2019

Sector

#Pharma

Subsector

• #R&D Services - Analytical services
• #R&D Services - Bioinformatics
• #R&D Services - CRO (Contract Research Organization)
• #R&D Services - Diagnostic services
• #R&D Services - Drug delivery
• #R&D Services - Proteomics
• #R&D Services - Screening
• #Other - AgBio
• #Pharma - Nucleic acid drugs
• #Pharma - Peptides
• #Pharma - Proteins
• #Pharma - Small molecule therapeutics
• #Medtech - Ophthalmic and optical devices
• #Professional Services - Business development
• #Professional Services - Communication & PR/IR
• #Professional Services - Deal arranger
• #Professional Services - Due diligence
• #Professional Services - Information provider
• #Professional Services - IT services
• #Professional Services - Legal services
• #Professional Services - Management consulting
• #Professional Services - Market access
• #Professional Services - Market research
• #Professional Services - Operations/Health & safety/Purchasing
• #Professional Services - Sales & Marketing
• #Professional Services - Technology transfer

Therapeutic areas

• #Conditions originating in the perinatal period

BioSimulytics offers an AI-powered cloud platform for computer-aided molecular simulation using Machine Learning technology combined with Quantum Chemistry for the digitisation of drug discovery and development, in particular Structure-Based Drug Design and Crystal Structure Prediction / Polymorph Control.